- EU could approve shot against new variant in 3-4 months
- Mask mandates to tackle Omicron come into force in England
- Omicron could outcompete Delta, South African disease expert says
- German and Austrian incidence rate falls, stable in Netherlands
- FDA panel to weigh Merck's antiviral drug